Press releases
- LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
- LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
- LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
- LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
- LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences
More ▼
Key statistics
As of last trade, LivaNova PLC (LIA:FRA) traded at 51.00, 14.35% above the 52 week low of 44.60 set on Oct 17, 2022.
52-week range
Markit short selling activity
Open | 51.00 |
---|---|
High | 51.00 |
Low | 51.00 |
Bid | 50.50 |
Offer | 52.00 |
Previous close | 50.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 53.52m |
Free float | 53.31m |
P/E (TTM) | -- |
Market cap | 3.01bn USD |
EPS (TTM) | -1.81 USD |
Data delayed at least 15 minutes, as of Feb 01 2023 07:04 GMT.
More ▼